Cardinal Health, US14149Y1082

Cardinal Health stock: Wells Fargo raises target to 321 dollars

Published on 11/21/2026 at 11:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Cardinal Health stock drew a higher Wells Fargo target after strong fiscal first-quarter results. The bank kept its Overweight rating.

Analyst target supports investor focus

  • Wells Fargo retained its Overweight rating after Cardinal Health reported strong fiscal first-quarter results.
  • The bank pointed to organic pharmaceutical growth and capital deployment as potential sources of upside.
  • The company continues to attract multiple analyst target changes after raising its fiscal 2027 outlook.
Cardinal Health, US14149Y1082, Illustration mit AI erstellt.

Wells Fargo raised its Cardinal Health price target on Tuesday, November 17, 2026, while maintaining an Overweight rating on the shares. The bank cited strong fiscal first-quarter results and the company's higher fiscal 2027 outlook. Markets Insider reported that Wells Fargo also sees potential upside from organic pharmaceutical growth and capital deployment.

What Wells Fargo highlighted

The target change followed Cardinal Health's strong fiscal first quarter and an improved fiscal 2027 earnings outlook. For investors, the assessment puts the focus on execution in the pharmaceutical business and on how effectively the company deploys capital.

Cardinal Health stock traded at 248.75 euros on Lang & Schwarz at 11:09 CET on Saturday, November 21, 2026. The quote provides a current trading reference for the weekend report, while the analyst action supplies the week's principal investor event.

Cardinal Health at a glance

  • Company: Cardinal Health, Inc.
  • ISIN: US14149Y1082
  • Quote: 248.75 euros on Lang & Schwarz, Saturday, November 21, 2026, at 11:09 CET
  • Analyst: Wells Fargo, Overweight rating

Broader market conditions remain relevant for healthcare distributors and other large US equities. Current market reports provide the wider trading context.

Follow further company developments and analyst updates on More news and analyses on Cardinal Health stock.

Disclaimer...
en | US14149Y1082 | CARDINAL HEALTH | boerse | 70541957 | bgmi